title: Toward quantitating the burden of glomerulonephritis in the United States.
abstract: Previous data attempting to quantitate the national burden of glomerulonephritis (GN) have been derived from regional biopsy series or end-stage renal disease registries. Wetmore et al. is the first to address this question based on claims data extracted from 2 large U.S. health care systems. Although there are limitations, it provides broad-based epidemiological data that demonstrate a significant underestimate of the extent of GN disease and provide an important first step in its quantitation.
authors.affiliation: Department of Medicine, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada. Electronic address: daniel.cattran@uhn.ca.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Cattran
mesh_terms: D001706:Biopsy; D005921:Glomerulonephritis; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic; D015995:Prevalence; D012189:Retrospective Studies; D014481:United States